Pyxis Oncology appoints Tom Civik as interim CEO Feb 6, 2026 04:11PM
Pyxis Oncology names Thomas Civik interim CEO as Sullivan steps down Feb 3, 2026 06:45AM
Why Jefferies sees these stocks as standout biotech plays in 2026 Dec 23, 2025 10:00AM
Pyxis Oncology Inc. (PYXS) PT Raised to $7 at H.C. Wainwright Dec 19, 2025 07:27AM
Pyxis Oncology Inc. (PYXS) PT Lowered to $5 at RBC Capital Dec 18, 2025 02:36PM


Nov 26, 2025 09:12AM Pyxis Oncology (PYXS) files $350M mixed shelf
Nov 24, 2025 07:04AM Pyxis Oncology Inc. (PYXS) PT Raised to $8 at Stephens
Nov 4, 2025 06:36AM Pyxis Oncology Inc. (PYXS) PT Raised to $7 at Guggenheim
Nov 3, 2025 08:04AM Pyxis Oncology, Inc. (PYXS) Misses Q3 EPS by 1c
Sep 4, 2025 05:41AM Guggenheim Starts Pyxis Oncology Inc. (PYXS) at Buy
Aug 14, 2025 05:50PM Pyxis Oncology, Inc. (PYXS) Tops Q2 EPS by 4c
May 15, 2025 04:47PM Pyxis Oncology, Inc. (PYXS) Misses Q1 EPS by 2c
Apr 25, 2025 01:18PM Pyxis Oncology (PYXS) Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin
Mar 19, 2025 06:34AM Pyxis Oncology, Inc. (PYXS) Misses Q4 EPS by 100c
Mar 18, 2025 04:02PM Pyxis Oncology Inc. (PYXS) PT Lowered to $6 at Jefferies
Feb 26, 2025 07:31AM Pyxis Oncology (PYXS) Granted FDA Fast Track Designation for PYX-201
Feb 4, 2025 07:31AM Pyxis Oncology (PYXS) Initiates New PYX-201 Combination Trial
Dec 23, 2024 06:49AM Pyxis Oncology Inc. (PYXS) PT Lowered to $5 at H.C. Wainwright
Dec 20, 2024 09:30AM Pyxis Oncology Inc. (PYXS) PT Lowered to $8; RBC Capital: 'We Would Be Buyers into 2025 Data'
Dec 19, 2024 04:08PM Pyxis Oncology (PYXS) Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201
Nov 21, 2024 06:53AM Pyxis Oncology Inc. (PYXS) PT Raised to $10 at RBC Capital
Nov 20, 2024 04:05PM Pyxis Oncology (PYXS) Reports Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
Nov 18, 2024 03:11PM Pyxis Oncology (PYXS) call put ratio 1 call to 1 put into data
Nov 18, 2024 05:43AM Pyxis Oncology (PYXS) call put ratio 1.3 calls to 1 put into investor event
Nov 15, 2024 11:03AM Pyxis Oncology (PYXS) call put ratio 1.6 calls to 1 put into investor event
Nov 12, 2024 04:52PM Pyxis Oncology, Inc. (PYXS) Misses Q3 EPS by 3c
Nov 12, 2024 05:10AM Pyxis Oncology (PYXS) call put ratio 2.9 calls to 1 put into data
Aug 16, 2024 06:46AM H.C. Wainwright Reiterates Buy Rating on Pyxis Oncology Inc. (PYXS)
Aug 15, 2024 07:54AM Pyxis Oncology, Inc. (PYXS) Tops Q2 EPS by 5c
Aug 7, 2024 04:08PM Stifel Starts Pyxis Oncology Inc. (PYXS) at Buy
Jul 26, 2024 05:45AM RBC Capital Reiterates Outperform Rating on Pyxis Oncology Inc. (PYXS)
Jun 10, 2024 06:33AM Pyxis Oncology (PYXS) Appoints Michael A. Metzger to its Board